KINGSVILLE, ON, July 31, 2025 /PRNewswire/ - Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) ("Greenway" or the "Company"), a cultivator of high-quality greenhouse cannabis for the Canadian market, has entered into a supply agreement with 4C LABS, a leading medical cannabis company located in the United Kingdom, focused on providing patients with world class medical cannabis products. Through the agreement the Company expects to supply high-quality, dried flower product to 4C LABS, a lea ...

Core Viewpoint - Dogecoin Cash Inc. has filed a U.S. provisional patent application for a software framework known as the Dogecoin Protocol, aimed at enhancing the interoperability of Dogecoin within decentralized applications [1][2][3]. Group 1: Patent Application Details - The application outlines methods for creating decentralized applications (dApps) that incorporate Dogecoin transaction capabilities and interact with both UTXO-based blockchains and smart-contract platforms [2]. - The application is expected to be formally assigned to Dogecoin Treasury Inc., a wholly owned subsidiary of Dogecoin Cash Inc. [2]. Group 2: Objectives and Use Cases - The filing is seen as a significant step in pursuing intellectual property protections to improve Dogecoin's interoperability [3]. - The DogP framework aims to support features such as tipping overlays, cross-chain NFT interactions, and token-gated dashboards utilizing Dogecoin transactions [4]. Group 3: Technical Overview - The application describes methods for transmitting blockchain transactions through a unified JSON schema that adapts to different chain types while maintaining client-side signature storage for security [4]. Group 4: Company Background - Dogecoin Cash Inc. is a publicly traded company that operates in the cannabis telemedicine sector and is involved in blockchain innovation [5]. - The company holds patents for a cannabis strain and a lozenge for hypertension treatment, and it is focused on leveraging digital assets and decentralized finance solutions [5].

Core Insights - Dogecoin Cash Inc. is preparing a U.S. Provisional Patent Application for the Dogecoin Protocol, aimed at creating a modular, blockchain-agnostic application architecture for integrating Dogecoin into decentralized applications without relying on bridges or wrapped tokens [1] - The company has established a wholly owned subsidiary, Dogecoin Treasury, Inc. (DTI), to accumulate DOGE through direct acquisition, mining operations, and other revenue streams, with the provisional patent application being filed by DTI [2] - The evaluation of the Dogecoin Protocol includes potential use cases such as cross-chain NFT minting settled in DOGE, DOGE-based tipping, token-gated DAOs, and decentralized application deployment [3] - The company aims to develop and protect the Dogecoin Protocol, with plans for a utility patent application and potential open-source release of DogP components [4] - Dogecoin Treasury, Inc. will manage intellectual property related to Dogecoin initiatives and aims to enhance the operational framework for cryptocurrency-related activities [5] Company Overview - Dogecoin Cash Inc. is publicly traded and also operates in the medical cannabis sector through its subsidiary PrestoDoctor, holding patents for cannabis strains and products [6] - The company is focused on blockchain innovation and developing digital asset initiatives, with its subsidiary MEME Coins Inc. holding DOG tokens as its sole digital asset [6]

TORONTO and GLIL YAM, Israel, July 11, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce the filing and effectiveness of a shelf registration statement (the "Shelf Registration") on Form F-3 with the Securities and Exchange Commission ("SEC").The Shelf Registration will allow the Company to offer and sell, from time to time, up to an aggregate of $50 million of its common shares, wa ...

Core Points - Vireo Growth Inc. announced the retirement of a US$10 million convertible note originally issued on November 1, 2024, and concurrently issued a new US$10 million convertible note as part of its refinancing initiatives [1] - The repayment and issuance of the convertible notes are classified as a "related party transaction" under Multilateral Instrument 61-101, exempting them from formal valuation and minority shareholder approval requirements [2] - The new convertible note was issued under exemptions from the registration requirements of the U.S. Securities Act and applicable Canadian and U.S. state securities laws [3] Company Overview - Vireo Growth Inc. was founded in 2014 as a pioneer in the medical cannabis industry, focusing on building a disciplined and execution-oriented platform while leveraging a national portfolio [4]

Core Insights - Dogecoin Cash Inc. has completed the acquisition of 2 billion Dogecoin Cash (DOG) tokens from Tipestry Inc. in exchange for 250,000 shares of MEME Class A Preferred Stock [1][2] - This acquisition increases Dogecoin Cash's total DOG holdings to 4,020,000,000 tokens, combining direct holdings and those through its subsidiary MEME Coins Inc. [2] Company Overview - Dogecoin Cash, Inc. (OTCQB: DOGP) operates in the medical cannabis telemedicine sector through its subsidiary PrestoDoctor and holds patented cannabis products [4] - The company is also involved in blockchain innovation and aims to leverage digital assets and decentralized finance (DeFi) solutions to create new market opportunities [4] Strategic Objectives - The acquisition aligns with MEME Coins Inc.'s goal to develop a blockchain-aligned infrastructure and token reserve, supporting potential blockchain-related initiatives [2]

Core Viewpoint - Vireo Growth Inc. has successfully refinanced its existing senior secured debt and expanded its credit capacity, resulting in significant interest savings and a stronger financial position for the company [1][4][5]. Group 1: Refinancing Details - The company closed a $120 million self-syndicated first lien term loan with leading banks, which refinances all existing senior secured obligations and is secured by a first-priority lien on substantially all assets [2][4]. - The three-year facility has an interest rate of 8.3% (1-month SOFR + 4.0%) and allows for prepayment at any time without penalty [2][3]. - Additionally, a $33 million second lien term loan was closed, featuring a $50 million accordion to support future strategic initiatives, with an interest rate of prime + 5.5% [3][4]. Group 2: Financial Impact - The refinancing is expected to generate over $10 million in annual interest savings, thereby enhancing the company's financial position and long-term shareholder value [1][4]. - The combined financing of $153 million strengthens the company's balance sheet with over $100 million in cash [1][4]. Group 3: Strategic Context - The refinancing follows a series of mergers that expanded Vireo's operational footprint and market leadership, consolidating and optimizing debt across the platform [4][5]. - The initiative reflects disciplined capital planning and strong institutional demand, with the senior facility being significantly oversubscribed [5][6]. Group 4: Leadership and Confidence - Lenders expressed confidence in the company's operating model, financial strategy, and leadership continuity, particularly the ongoing role of CEO John Mazarakis [6][7]. - The strong response from lending partners indicates progress made by the company and confidence in its ability to execute its long-term strategy [7].

Core Viewpoint - AYR Wellness Inc. is facing potential ownership reclamation and sale of its subsidiary's equity interests due to alleged defaults under a Pledge Agreement, while simultaneously extending a waiver agreement to negotiate with senior lenders [1][2][3]. Group 1: Notification of Disposition and Defaults - AYR Wellness received a Notification of Disposition of Collateral from the Agent, indicating potential defaults under the Pledge Agreement [1][2]. - The Agent intends to reclaim and sell all equity interests in PA Natural Medicine LLC, which operates licensed medical cannabis dispensaries in Pennsylvania [2]. Group 2: Waiver Agreement and Extensions - The Second Amendment extends the temporary waiver period to July 11, 2025, allowing AYR additional time to negotiate with senior lenders [3]. - The Original Agreement provided a waiver for certain defaults related to the delay in filing interim financial statements and specific payment defaults [3][4]. - The extension does not permanently waive existing defaults but facilitates ongoing discussions to address financial obligations [4]. Group 3: Company Overview - AYR Wellness is a vertically integrated U.S. multi-state cannabis operator with over 90 licensed dispensaries and a portfolio of cannabis CPG brands [6]. - The company aims to deliver high-quality cannabis products while positively impacting its team members and communities [6].

Core Insights - Cronos Group Inc. is expanding its distribution of the PEACE NATURALS medical cannabis brand in Switzerland through a partnership with Dascoli Pharma AG, a Swiss company specializing in medical cannabis supply and distribution [1][2] - The partnership aims to provide high-quality medical cannabis to Swiss patients and aligns with Cronos' mission to offer borderless cannabis products in European medical markets [2] - Cronos will supply PEACE NATURALS-branded cannabis flower to Dascoli for distribution across its established medical network in Switzerland, marking a significant step in Cronos' international growth strategy [2] Company Overview - Cronos Group Inc. is a global cannabinoid company focused on advancing cannabis research, technology, and product development, with a diverse international brand portfolio including Spinach, PEACE NATURALS, and Lord Jones [4] - The company is committed to building disruptive intellectual property and enhancing the consumer experience through its iconic brand portfolio [4] Partner Overview - Dascoli Pharma AG is a Swiss pharmaceutical firm that focuses on medical cannabis manufacturing and distribution across wholesale and retail channels, providing compliant cannabinoid therapies to patients, pharmacies, and clinics [5] - Dascoli is recognized as a leading cannabinoid retailer in Switzerland, offering next-day home delivery services for patients [5] Product Availability - PEACE NATURALS medical cannabis products are now available in multiple countries, including Australia, Canada, Germany, Israel, Malta, Switzerland, and the UK [3]

Core Business Overview - Dogecoin Cash Inc. (DOGP) is a publicly traded company that operates in the cannabis telemedicine sector and blockchain innovation, holding a patented cannabis strain and product for hypertension treatment [6][7] - The company focuses on developing and commercializing cannabis-based products, including CBD-infused wellness solutions and pharmaceutical-grade formulations, while seeking to expand its portfolio through strategic partnerships and acquisitions [7] Blockchain and Digital Asset Strategy - Dogecoin Cash Inc. is actively exploring blockchain technology and decentralized finance (DeFi) applications, aiming to enhance transparency, security, and efficiency in cannabis supply chains and financial transactions [8][11] - The company is assessing potential utility tokens, NFTs, and other crypto-related ventures that align with its long-term vision [9] Recent Acquisition - MEME COINS INC., a subsidiary of Dogecoin Cash Inc., has entered into an agreement to acquire 2 billion Dogecoin Cash (DOG) tokens, which will double its total DOG holdings to approximately 4.02 billion tokens without any dilution [1][3] - In exchange for the DOG tokens, MEME COINS INC. will issue 250,000 shares of Preferred Stock to Tipestry, Inc., maintaining its status as a wholly controlled subsidiary of DOGP [2][3] Strategic Growth Initiatives - Dogecoin Cash Inc. is committed to pursuing strategic mergers, acquisitions, and joint ventures to enhance its influence in both the cannabis and blockchain sectors [10] - The company aims to broaden its investor base and diversify revenue streams while leveraging emerging technologies to drive growth [11]